Is Cellebrite DI Ltd. overvalued or undervalued?

As of 14 November 2025, Cellebrite DI Ltd. moved from fair to attractive in its valuation grade. The company appears to be undervalued, particularly given its current Price to Book Value of 10.89, an EV to EBITDA ratio of 50.27, and a negative ROE of -53.38%. In comparison to peers, Clearwater Analytics Holdings, Inc. has a P/E of 12.49 and an EV to EBITDA of 115.40, while Clear Secure, Inc. shows a P/E of 19.95 and an EV to EBITDA of 22.81, highlighting Cellebrite's relative valuation challenges.
Despite some recent volatility, Cellebrite's stock has outperformed the S&P 500 over the three-year period with a return of 280.41% compared to 70.17%. However, its year-to-date performance shows a decline of -16.25% against the S&P 500's gain of 14.49%, indicating the stock's mixed performance in the short term.